Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NSIS-B.CO
- Price
- 471.20
- Stock movement down
- -1.30 (-0.31%)
- Company name
- Exchange
- (CO ,
- Currency
- DKK )
- Sector
- Basic Materials >Specialty Chemicals
- Market cap
- 172.65B
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- 1.91%
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 26.27
- PEG
- -
- EPS growth
- -
- 1 year return
- -3.61%
- 3 year return
- -3.24%
- 5 year return
- 1.81%
- 10 year return
- 1.96%
Last updated: 2025-09-17
DIVIDENDS
NSIS-B.CO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 419.80 |
| Daily high | 424.30 |
| Daily low | 417.60 |
| Daily Volume | 593K |
| All-time high | 537.20 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 8.00 |
| Ex-div date | 21 Aug 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NSIS-B.CO | S&P500 | |
| Current price drop from All-time high | -21.97% | -1.06% |
| Highest price drop | -52.86% | -56.47% |
| Date of highest drop | 27 Oct 2008 | 9 Mar 2009 |
| Avg drop from high | -14.21% | -10.99% |
| Avg time to new high | 23 days | 12 days |
| Max time to new high | 1127 days | 1805 days |
COMPANY DETAILS
Marketcap
172.65B
Marketcap category
Large-cap
Description
Employees
Investor relations
-
SEC filings
CEO
Country
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the ...
October 23, 2025
Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step...
October 21, 2025
Manufacturing Day at Novonesis Tue Micheelsen, President, Novonesis North America and Carolyn Lee, President & Executive Director of the Manufacturing Institute accompany students on a Novonesis tour ...
October 6, 2025
Novozymes (CPSE:NSIS B) might not be grabbing headlines with earth-shaking news right now, but that doesn’t mean investors should overlook what’s happening under the surface. Even modest moves can sig...
September 9, 2025
Novonesis and Novo Nordisk have announced a research partnership to explore how the gut microbiome influences metabolic health, aiming to develop synbiotic food supplements and identify novel health b...
September 8, 2025
Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN, Denmark – Septemb...
September 8, 2025
Corbion’s Supervisory Board announces it has nominated Per Falholt for appointment to the Supervisory Board for a term of four years as of the Annual General Meeting of Shareholders (AGM) in May 2026....
August 26, 2025
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President & CEO: “I’m very pleased with 9% organic ...
August 21, 2025
9% organic sales growth in H1 and FY outlook range narrowed to 6-8% Ester Baiget, President & CEO: “I’m very pleased with 9% organic sales growth in the first half of the year. Demand for our biosolut...
August 21, 2025
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and signi...
August 20, 2025
Next page